These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29858660)

  • 41. Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus.
    Davidson MH
    Postgrad Med; 2014 May; 126(3):56-65. PubMed ID: 24918792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
    Penno G; Garofolo M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methodological quality of systematic reviews on treatments for osteoporosis: A cross-sectional study.
    Tsoi AKN; Ho LTF; Wu IXY; Wong CHL; Ho RST; Lim JYY; Mao C; Lee EKP; Chung VCH
    Bone; 2020 Oct; 139():115541. PubMed ID: 32730932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Most systematic reviews of high methodological quality on psoriasis interventions are classified as high risk of bias using ROBIS tool.
    Gómez-García F; Ruano J; Gay-Mimbrera J; Aguilar-Luque M; Sanz-Cabanillas JL; Alcalde-Mellado P; Maestre-López B; Carmona-Fernández PJ; González-Padilla M; García-Nieto AV; Isla-Tejera B
    J Clin Epidemiol; 2017 Dec; 92():79-88. PubMed ID: 28893571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
    Silva Júnior WS; Godoy-Matos AF; Kraemer-Aguiar LG
    Biomed Res Int; 2015; 2015():816164. PubMed ID: 26146634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review.
    Turdu G; Gao H; Jiang Y; Kabas M
    Future Med Chem; 2018 May; 10(10):1229-1239. PubMed ID: 29749760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of dipeptidyl peptidase-4 inhibitors on beta-cell function and insulin resistance in type 2 diabetes: meta-analysis of randomized controlled trials.
    Lyu X; Zhu X; Zhao B; Du L; Chen D; Wang C; Liu G; Ran X
    Sci Rep; 2017 Mar; 7():44865. PubMed ID: 28322294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A flood tide of systematic reviews on endodontic posts: methodological assessment using of R-AMSTAR.
    Schmitter M; Sterzenbach G; Faggion CM; Krastl G
    Clin Oral Investig; 2013 Jun; 17(5):1287-94. PubMed ID: 23436119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Acupuncture in the Treatment of COPD: An Overview of Systematic Reviews.
    Chun L; Li X; Feng Z; Xie Y; Li J
    Int J Gen Med; 2021; 14():1079-1092. PubMed ID: 33790637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of systematic reviews and meta-analyses published in pediatric surgery.
    Salim A; Mullassery D; Losty PD
    J Pediatr Surg; 2017 Nov; 52(11):1732-1735. PubMed ID: 28830620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.
    Patil HR; Al Badarin FJ; Al Shami HA; Bhatti SK; Lavie CJ; Bell DS; O'Keefe JH
    Am J Cardiol; 2012 Sep; 110(6):826-33. PubMed ID: 22703861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.
    Zhong J; Maiseyeu A; Davis SN; Rajagopalan S
    Circ Res; 2015 Apr; 116(8):1491-504. PubMed ID: 25858071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
    Mulvihill EE
    Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methodological quality of systematic reviews on influenza vaccination.
    Remschmidt C; Wichmann O; Harder T
    Vaccine; 2014 Mar; 32(15):1678-84. PubMed ID: 24513008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis.
    Overbeek JA; Bakker M; van der Heijden AAWA; van Herk-Sukel MPP; Herings RMC; Nijpels G
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3004. PubMed ID: 29573125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health literacy in type 2 diabetes patients: a systematic review of systematic reviews.
    Caruso R; Magon A; Baroni I; Dellafiore F; Arrigoni C; Pittella F; Ausili D
    Acta Diabetol; 2018 Jan; 55(1):1-12. PubMed ID: 29129000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis.
    Zhang X; Zhao Q
    J Hypertens; 2016 Feb; 34(2):167-75. PubMed ID: 26682782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety.
    Jain R
    Adv Ther; 2015 Nov; 32(11):1065-84. PubMed ID: 26578430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.
    Guthrie RM
    Postgrad Med; 2015 Jun; 127(5):463-79. PubMed ID: 25956345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critical appraisal of methodological quality of Systematic Reviews and Meta-analysis in Paediatric Dentistry journals.
    Jayaraman J; Nagendrababu V; Pulikkotil SJ; Innes NP
    Int J Paediatr Dent; 2018 Nov; 28(6):548-560. PubMed ID: 30070003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.